Single piece PMMA lens, AC depth: 4.7.
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
An injectable IOL, single-use injector for the IOL and post-op protective eye-shield all packaged in one handy, ready-to-use system pack.
Medicine Products:(Date:9/8/2008)... WASHINGTON, Sept. 8 /PRNewswire-USNewswire/ -...ounced today it has clarified its policy on,assist...particular focus on,inpatients and residents of VA...nts with limited access to community voter registr...te and local election officials and,non-partisan g...
(Date:9/8/2008)..., The probability of someone cheating during the ...percent. "It,s very high," says Genevive Beaulieu-...,s Department of Psychology. , "These numbers i...of intentions things don,t always turn out the way...y people are willing to conduct themselves in ways...
(Date:9/8/2008)... Researchers say it,s the ,pain of paying, that dr.... 8 (HealthDay News) -- You spend less when paying... cards or gift certificates, according to a new st...r issue of the Journal of Experimental Psychology...they have to estimate expenses in detail. , "T...
(Date:9/8/2008)... PHOENIX, Sept. 8 /PRNewswire-FirstCall/ -- Nu...in stabilized rice bran research and,technology, a...ss Civic,Leadership Center named NutraCea as a fin...egory of Corporate Stewardship, Small/Midsize Busi...Corporate Stewardship Awards,this year," said BCLC...
Breaking Medicine News(10 mins):Health News:VA Clarifies Voter Registration Regulations 2Health News:Infidelity dissected: New research on why people cheat 2Health News:Buyers Spend More With Non-Cash Purchases 2Health News:U.S. Chamber Recognizes NutraCea for Strong Corporate Stewardship 2(Date:9/8/2008)...dd to body of clinical evidence demonstrating the ...r treatment of stress urinary ...t. 8 /- A new study published in the,...l analyzes data of an,11-year follow up study on t...l tape (TVT) as a treatment for stress urinary inc...
(Date:9/8/2008)...ept. 8 /- Novo Nordisk (NYS...data from a phase 3 clinical study,(LEAD(TM) 4) to...ociation,for the Study of Diabetes that demonstrat..., a human GLP-1 analog, to metformin and rosiglita... improved blood glucose lowering,(HbA1c), weight l...
(Date:9/6/2008)...monstrate Safety and Efficacy of First-in-Class Ne...he Treatment of Acute Migraine, LONDON, Sept. 6 /...nnovative biotechnology company focusing on therap...d Phase II results of its lead compound COL-144,in...ated that COL-144 was,safe and effective in reliev...
(Date:9/5/2008)...OWN, W.Va., Sept. 5 /PRNewswire-USNewswire/ -- Can...ental fog known as chemobrain. Now in,animal studi...iscovered,that injections of N-acetyl cysteine (NA...at breast cancer chemotherapy drugs sometimes indu...the September issue of the,journal Metabolic Brain...
Breaking Medicine Technology:New Study Offers More Than a Decade of Evidence for Minimally-Invasive Surgery to Treat Female Incontinence 2New Study Offers More Than a Decade of Evidence for Minimally-Invasive Surgery to Treat Female Incontinence 3Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 2Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 3Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 4Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 5Phase II Results of COL-144 Presented at European Headache and Migraine Trust International Congress 2008 2Study Suggests a Possible Way to Offset Chemobrain Memory Loss 2Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert 28R 29 Systems and Xpert 28TM 29 Molecular Diagnostic Tests Including Xpert MRSA 7179 1Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert 28R 29 Systems and Xpert 28TM 29 Molecular Diagnostic Tests Including Xpert MRSA 7179 2Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert 28R 29 Systems and Xpert 28TM 29 Molecular Diagnostic Tests Including Xpert MRSA 7179 3Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert 28R 29 Systems and Xpert 28TM 29 Molecular Diagnostic Tests Including Xpert MRSA 7179 4International Federation Lilly Agreement Will Allow Significant Increase in MDR TB Programmes 7174 1International Federation Lilly Agreement Will Allow Significant Increase in MDR TB Programmes 7174 2International Federation Lilly Agreement Will Allow Significant Increase in MDR TB Programmes 7174 3Three Astex Drug Candidates to be Presented at the 2007 American Society of Hematology Annual Meeting 1994 1Three Astex Drug Candidates to be Presented at the 2007 American Society of Hematology Annual Meeting 1994 2Three Astex Drug Candidates to be Presented at the 2007 American Society of Hematology Annual Meeting 1994 3Southern California institutions to collaborate on stem cell research 1377 1Southern California institutions to collaborate on stem cell research 1377 2Southern California institutions to collaborate on stem cell research 1377 3...ril 16, 2007 /PRNewswire-FirstCall/ -- ACCESS,PHAR...studies of,the mechanism of ProLindac,s anticancer...Association for Cancer Research (AACR) 2007,annual...ion Center.,The two poster presentations describe ...ors at two prominent institutes in France. , "We a...
... Mass., April 16, 2007 /PRNewswire-FirstCall/ --,G...eted study of,Renvela(TM) (sevelamer carbonate) ac...stically significant reduction in serum,phosphorus...y,disease who are not on dialysis. , Patients trea...tion in calcium-phosphorus product and in LDL chol...
Other Medicine Technology:Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 2Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 3Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 4Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease 2Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease 3